| Primary |
| Product Used For Unknown Indication |
64.5% |
| Dyspepsia |
8.7% |
| Drug Use For Unknown Indication |
5.8% |
| Drug Exposure During Pregnancy |
4.3% |
| Breast Cancer |
2.9% |
| Chemotherapy |
2.9% |
| Impaired Gastric Emptying |
2.2% |
| Sleep Apnoea Syndrome |
1.4% |
| Snoring |
1.4% |
| Abdominal Distension |
0.7% |
| Gastrooesophageal Reflux Disease |
0.7% |
| Hiv Infection |
0.7% |
| Lactation Disorder |
0.7% |
| Lipids Increased |
0.7% |
| Malaise |
0.7% |
| Sedation |
0.7% |
| Vomiting |
0.7% |
|
| Breast Discomfort |
9.1% |
| Dyspnoea |
9.1% |
| Ventricular Arrhythmia |
9.1% |
| Weight Decreased |
9.1% |
| Acute Myocardial Infarction |
4.5% |
| Arrhythmia |
4.5% |
| Atrioventricular Block |
4.5% |
| Chest Discomfort |
4.5% |
| Chest Pain |
4.5% |
| Neurotoxicity |
4.5% |
| Oedema Peripheral |
4.5% |
| Product Quality Issue |
4.5% |
| Sudden Cardiac Death |
4.5% |
| Tardive Dyskinesia |
4.5% |
| Tetany |
4.5% |
| Torsade De Pointes |
4.5% |
| Umbilical Artery Hypoplasia |
4.5% |
| Visual Impairment |
4.5% |
|
| Secondary |
| Product Used For Unknown Indication |
43.1% |
| Drug Use For Unknown Indication |
20.7% |
| Breast Cancer |
3.7% |
| Pain |
3.3% |
| Depression |
3.1% |
| Hypertension |
2.6% |
| Sedation |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Chemotherapy |
2.0% |
| Hyperemesis Gravidarum |
1.9% |
| Vomiting |
1.9% |
| Analgesic Therapy |
1.9% |
| Parkinson's Disease |
1.9% |
| Prophylaxis |
1.9% |
| Anxiety |
1.7% |
| Gastritis |
1.3% |
| Muscle Spasms |
1.2% |
| Prophylaxis Of Nausea And Vomiting |
1.2% |
| Premedication |
1.2% |
| Gastroenteritis |
1.1% |
|
| Vomiting |
20.5% |
| Dyspnoea |
8.5% |
| Intentional Overdose |
5.1% |
| Maternal Exposure During Pregnancy |
5.1% |
| Torsade De Pointes |
5.1% |
| Chest Discomfort |
4.5% |
| Electrocardiogram Qt Prolonged |
4.5% |
| Glossodynia |
4.5% |
| Haemorrhage |
4.5% |
| Atrioventricular Block Complete |
4.0% |
| Fatigue |
4.0% |
| Gastric Cancer |
4.0% |
| Subileus |
4.0% |
| Hepatocellular Injury |
3.4% |
| Liver Function Test Abnormal |
3.4% |
| Mucosal Inflammation |
3.4% |
| Thrombocytopenia |
3.4% |
| Pancreatitis Acute |
2.8% |
| Respiratory Depth Decreased |
2.8% |
| Burning Sensation |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.0% |
| Drug Use For Unknown Indication |
18.5% |
| Prophylaxis |
8.2% |
| Nausea |
5.4% |
| Hypertension |
5.0% |
| Pain |
4.7% |
| Rheumatoid Arthritis |
3.0% |
| Breast Cancer |
2.9% |
| Depression |
2.8% |
| Constipation |
2.7% |
| Prophylaxis Of Nausea And Vomiting |
2.5% |
| Parkinson's Disease |
2.4% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Diabetes Mellitus |
1.6% |
| Hiv Infection |
1.6% |
| Vomiting |
1.6% |
| Non-small Cell Lung Cancer |
1.5% |
| Gastric Cancer |
1.5% |
| Osteoporosis |
1.5% |
| Asthma |
1.4% |
|
| Vomiting |
21.0% |
| Weight Decreased |
6.6% |
| Pulmonary Embolism |
6.1% |
| Pyrexia |
5.7% |
| Renal Failure Acute |
5.5% |
| Thrombocytopenia |
5.2% |
| Weight Increased |
4.5% |
| Death |
4.4% |
| Sepsis |
4.4% |
| Neutropenic Sepsis |
3.8% |
| Somnolence |
3.7% |
| Urinary Tract Infection |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Pneumonia |
3.6% |
| Nausea |
3.5% |
| Malaise |
3.4% |
| Tremor |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
| Dyspnoea |
2.7% |
| Renal Failure |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
30.3% |
| Depression |
12.7% |
| Analgesic Therapy |
7.3% |
| Sedation |
7.3% |
| Neck Pain |
5.5% |
| Ear Infection |
4.2% |
| Psychotic Disorder |
4.2% |
| Extrapyramidal Disorder |
3.6% |
| Post-traumatic Stress Disorder |
3.6% |
| Back Pain |
3.0% |
| Muscle Spasms |
3.0% |
| Gastric Ph Decreased |
2.4% |
| Pain |
2.4% |
| Pulmonary Arterial Hypertension |
2.4% |
| Dyspepsia |
1.8% |
| Neuropathic Ulcer |
1.8% |
| Pain Management |
1.8% |
| Pulmonary Hypertension |
1.2% |
| Dementia Alzheimer's Type |
0.6% |
| Dementia With Lewy Bodies |
0.6% |
|
| Drug Interaction |
16.7% |
| Syncope |
10.0% |
| Coagulopathy |
6.7% |
| Hypokalaemia |
6.7% |
| Muscle Rigidity |
6.7% |
| Premature Labour |
6.7% |
| Anuria |
3.3% |
| Balance Disorder |
3.3% |
| Decreased Appetite |
3.3% |
| Hyperhidrosis |
3.3% |
| Hypotonia |
3.3% |
| Liver Function Test Abnormal |
3.3% |
| Maternal Exposure During Pregnancy |
3.3% |
| Muscular Weakness |
3.3% |
| Pregnancy After Post Coital Contraception |
3.3% |
| Renal Failure Acute |
3.3% |
| Respiratory Failure |
3.3% |
| Rhinorrhoea |
3.3% |
| Tachycardia |
3.3% |
| Tinnitus |
3.3% |
|
